Concepedia

Tommy Rampling

TR

Statistics

Publications

45

Citations

11.9K

H-Index

30

Active since

2003

Affiliations

University College London(Current)

University of Oxford

Jenner Institute

Imperial College London

UCL Biomedical Research Centre

Tommy Rampling is an author at University College London specializing in medicine, covid-19, and epidemiology.

ORCID

Top concepts

Publications per year

2003–2025

45

Publications

45

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2020 · 5K citations · Full text

Clinical features and management of human monkeypox: a retrospective observational study in the UK

Hugh Adler, Susan Gould, Paul Hine et al. · The Lancet Infectious Diseases · 2022 · 1.2K citations · Full text

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2021 · 1.2K citations · Full text

Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial

Xinxue Liu, R. H. Shaw, Arabella Stuart et al. · The Lancet · 2021 · 539 citations · Full text

, , +7

Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study

Dan Frampton, Tommy Rampling, Aidan Cross et al. · The Lancet Infectious Diseases · 2021 · 455 citations · Full text

1–5 of 45